Maxim Biomedical, Inc. Announces New Minority Investment Partner and Appoints Jonathan Maa as CEO
Summary
Jason Gray serves as Head of Investment Team at Pritzker Vlock Capital Management (PVCM). "We are passionate about companies that matter, about excellently run businesses, and about growth and MaximBio has all three. We admire the long history of MaximBio and look forward to partnering with Jonathan and the team to support the companys business going forward," said investor Jason Gray.As part of the shift to the next generation of MaximBio, Jonathan Maa is transitioning from the role of Chief Operating Officer to the role of Chief Executive Officer. My goal in bringing on our new investment partners and in assuming the role of CEO is all about positioning MaximBio to leverage our core platform to serve our mission of improving patient outcomes. Our mission is to support private and public partners in the creation of diagnostic products that are affordable, accessible, and enable actionable testing to improve patient outcomes around the globe.